CtrlK
CAH
NYSE
Health Care
$228.52
USD
-$0.20 (-0.09%)
At close: Jul 17, 2026, 4:00 PM EDT
Market Cap:
$54.40B
Volume:
2.1M
Previous Close
$228.72
Day Range
$228.43 - $233.22
52 Week Range
$137.75 - $243.21
Average Volume (10 Days)
2.7M
P/E Ratio (TTM)
34.98
Dividend Yield
0.90%
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. The company is headquartered in Dublin Ohio, Ohio and currently employs 57,700 full-time employees. The firm is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The firm also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as it owns urology MSO. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The firm connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.
CEO
Mr. Jason Hollar
Headquaters
Dublin Ohio, OHIO, US
Founded
1983
Employees
57,700
K.C. Pharmaceuticals initiated a nationwide recall of over 3.1 million bottles of eye drops sold at major retailers including CVS, Walgreens, and Kroger due to lack of assurance of sterility. The FDA classified this as a Class II recall, indicating potential for temporary or medically reversible health effects. The recall affects eight product types distributed through pharmacy chains where Cardinal Health operates.
0
0
K.C. Pharmaceuticals initiated a voluntary recall of more than 3.1 million bottles of eye drops sold at CVS, Walgreens, Kroger, H-E-B, and Walmart due to lack of sterility assurance. The FDA classified this as a Class II recall, indicating potential temporary health consequences but low risk of serious harm. Eight product types are affected with expiration dates ranging from April to October 2025.
0
0
